Matches in SemOpenAlex for { <https://semopenalex.org/work/W2444596056> ?p ?o ?g. }
- W2444596056 endingPage "46370" @default.
- W2444596056 startingPage "46354" @default.
- W2444596056 abstract "// Sepp R. Jansen 1, 4 , Wilfred J. Poppinga 1 , Wim de Jager 1 , Frank Lezoualc’h 2 , Xiaodong Cheng 3 , Thomas Wieland 4 , Stephen J. Yarwood 5 , Reinoud Gosens 1 , Martina Schmidt 1 1 Department of Molecular Pharmacology, Groningen Research Institute for Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands 2 Inserm UMR-1048, Institut des Maladies Métaboliques et Cardiovasculaires, Université Toulouse III, Toulouse, France 3 Department of Integrative Biology & Pharmacology, Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas, Houston, TX, USA 4 Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany 5 School of Life Sciences, Heriot-Watt University, Edinburgh, Scotland Correspondence to: Sepp R. Jansen, email: sepp.jansen@medma.uni-heidelberg.de Keywords: PGE 2 , Epac, β-catenin, Ezrin, EMT Received: January 12, 2016 Accepted: June 02, 2016 Published: June 17, 2016 ABSTRACT In epithelial cells, β-catenin is localized at cell-cell junctions where it stabilizes adherens junctions. When these junctions are disrupted, β-catenin can translocate to the nucleus where it functions as a transcriptional cofactor. Recent research has indicated that PGE 2 enhances the nuclear function of β-catenin through cyclic AMP. Here, we aim to study the role of the cyclic AMP effector Epac in β-catenin activation by PGE 2 in non-small cell lung carcinoma cells. We show that PGE 2 induces a down-regulation of E-cadherin, promotes cell migration and enhances β-catenin translocation to the nucleus. This results in β-catenin-dependent gene transcription. We also observed increased expression of Epac1. Inhibition of Epac1 activity using the CE3F4 compound or Epac1 siRNA abolished the effects of PGE 2 on β-catenin. Further, we observed that Epac1 and β-catenin associate together. Expression of an Epac1 mutant with a deletion in the nuclear pore localization sequence prevents this association. Furthermore, the scaffold protein Ezrin was shown to be required to link Epac1 to β-catenin. This study indicates a novel role for Epac1 in PGE 2 -induced EMT and subsequent activation of β-catenin." @default.
- W2444596056 created "2016-06-24" @default.
- W2444596056 creator A5004758910 @default.
- W2444596056 creator A5021023081 @default.
- W2444596056 creator A5031590936 @default.
- W2444596056 creator A5032976787 @default.
- W2444596056 creator A5042049356 @default.
- W2444596056 creator A5059726330 @default.
- W2444596056 creator A5060340541 @default.
- W2444596056 creator A5073278981 @default.
- W2444596056 creator A5080619609 @default.
- W2444596056 date "2016-06-17" @default.
- W2444596056 modified "2023-10-05" @default.
- W2444596056 title "Epac1 links prostaglandin E2 to β-catenin-dependent transcription during epithelial-to-mesenchymal transition" @default.
- W2444596056 cites W1922027332 @default.
- W2444596056 cites W1967182435 @default.
- W2444596056 cites W1967482860 @default.
- W2444596056 cites W1975834956 @default.
- W2444596056 cites W1976359234 @default.
- W2444596056 cites W1985733899 @default.
- W2444596056 cites W1988553303 @default.
- W2444596056 cites W1989569830 @default.
- W2444596056 cites W1989734503 @default.
- W2444596056 cites W1996683094 @default.
- W2444596056 cites W2000119414 @default.
- W2444596056 cites W2000925161 @default.
- W2444596056 cites W2004768943 @default.
- W2444596056 cites W2006419043 @default.
- W2444596056 cites W2017729871 @default.
- W2444596056 cites W2025941955 @default.
- W2444596056 cites W2029488295 @default.
- W2444596056 cites W2031279996 @default.
- W2444596056 cites W2035870242 @default.
- W2444596056 cites W2036446689 @default.
- W2444596056 cites W2042647961 @default.
- W2444596056 cites W2044576721 @default.
- W2444596056 cites W2048653810 @default.
- W2444596056 cites W2049112891 @default.
- W2444596056 cites W2050089891 @default.
- W2444596056 cites W2058219230 @default.
- W2444596056 cites W2058349560 @default.
- W2444596056 cites W2066094132 @default.
- W2444596056 cites W2069228549 @default.
- W2444596056 cites W2072000048 @default.
- W2444596056 cites W2074883812 @default.
- W2444596056 cites W2076128131 @default.
- W2444596056 cites W2077835151 @default.
- W2444596056 cites W2078623451 @default.
- W2444596056 cites W2085086233 @default.
- W2444596056 cites W2086747104 @default.
- W2444596056 cites W2090266806 @default.
- W2444596056 cites W2102563932 @default.
- W2444596056 cites W2104532440 @default.
- W2444596056 cites W2106385366 @default.
- W2444596056 cites W2116261578 @default.
- W2444596056 cites W2116569509 @default.
- W2444596056 cites W2117419186 @default.
- W2444596056 cites W2118411712 @default.
- W2444596056 cites W2121660257 @default.
- W2444596056 cites W2123275987 @default.
- W2444596056 cites W2124289149 @default.
- W2444596056 cites W2141261480 @default.
- W2444596056 cites W2144517964 @default.
- W2444596056 cites W2146603157 @default.
- W2444596056 cites W2148558073 @default.
- W2444596056 cites W2153522091 @default.
- W2444596056 cites W2153561951 @default.
- W2444596056 cites W2156624679 @default.
- W2444596056 cites W2157035381 @default.
- W2444596056 cites W2171241069 @default.
- W2444596056 doi "https://doi.org/10.18632/oncotarget.10128" @default.
- W2444596056 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5216803" @default.
- W2444596056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27344171" @default.
- W2444596056 hasPublicationYear "2016" @default.
- W2444596056 type Work @default.
- W2444596056 sameAs 2444596056 @default.
- W2444596056 citedByCount "20" @default.
- W2444596056 countsByYear W24445960562017 @default.
- W2444596056 countsByYear W24445960562018 @default.
- W2444596056 countsByYear W24445960562019 @default.
- W2444596056 countsByYear W24445960562020 @default.
- W2444596056 countsByYear W24445960562021 @default.
- W2444596056 countsByYear W24445960562022 @default.
- W2444596056 countsByYear W24445960562023 @default.
- W2444596056 crossrefType "journal-article" @default.
- W2444596056 hasAuthorship W2444596056A5004758910 @default.
- W2444596056 hasAuthorship W2444596056A5021023081 @default.
- W2444596056 hasAuthorship W2444596056A5031590936 @default.
- W2444596056 hasAuthorship W2444596056A5032976787 @default.
- W2444596056 hasAuthorship W2444596056A5042049356 @default.
- W2444596056 hasAuthorship W2444596056A5059726330 @default.
- W2444596056 hasAuthorship W2444596056A5060340541 @default.
- W2444596056 hasAuthorship W2444596056A5073278981 @default.
- W2444596056 hasAuthorship W2444596056A5080619609 @default.
- W2444596056 hasBestOaLocation W24445960561 @default.
- W2444596056 hasConcept C121608353 @default.
- W2444596056 hasConcept C126322002 @default.
- W2444596056 hasConcept C137620995 @default.